Afficher la notice abrégée

dc.contributor.editorFranceschini, Gianluca
dc.contributor.editorSanchez, Alejandro Martin
dc.contributor.editorMasetti, Riccardo
dc.date.accessioned2022-05-06T11:18:44Z
dc.date.available2022-05-06T11:18:44Z
dc.date.issued2022
dc.identifierONIX_20220506_9783036538020_33
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/80967
dc.description.abstractBreast cancer is acknowledged as an international priority in healthcare. It is currently the most common cancer in women worldwide, with demographic trends indicating a continuous increase in incidence. Over the years, increasing efforts and resources have been devoted to the search for a systematic and optimized strategy in breast cancer diagnosis and treatment. Today, the Breast Unit model is considered the gold standard in order to ensure optimal patient-centered and research-based clinical services through multidisciplinary and integrated management.Surgical treatment has gradually evolved toward less aggressive approaches with the adoption of new therapeutic strategies. The evolution of evidence-based guidelines in such leading disciplines as radiation and medical oncology has led to a steady improvement in survival rates. This Special Issue will highlight innovations in the integrated management of breast cancer, their potential advantages, and the many open issues that still need to be properly defined and addressed.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacologyen_US
dc.subject.othermetastatic breast cancer
dc.subject.otherbreast surgery
dc.subject.otherimmune system
dc.subject.othermetabolic derangements
dc.subject.otherprecision medicine
dc.subject.otherintegrated therapies
dc.subject.otheradvanced breast cancer
dc.subject.othermTOR inhibitor
dc.subject.otherCDK4/6 inhibitor
dc.subject.otherendocrine resistance
dc.subject.otherbreast cancer
dc.subject.otherpregnancy
dc.subject.otherchemotherapy
dc.subject.othertailoring
dc.subject.otherpersonalization
dc.subject.otherDataMart
dc.subject.otherreal world data
dc.subject.otherpredictive model
dc.subject.otherhealthcare
dc.subject.otherbreast-conserving surgery
dc.subject.othernon-palpable breast lesions
dc.subject.otherimage-guided localization
dc.subject.otherpreoperative breast localization
dc.subject.otherbreast ultrasound
dc.subject.otherlarge database
dc.subject.otherstandardized data collection
dc.subject.othernetworks
dc.subject.othernipple-sparing mastectomy
dc.subject.otherimmediate breast reconstruction
dc.subject.otheracellular dermal matrix (ADM)
dc.subject.otheraesthetic and oncological outcomes
dc.subject.otherquality of life
dc.subject.otherrare breast cancer
dc.subject.otherosteoclast-like giant cells
dc.subject.othergene profiling
dc.subject.otherOncotype Dx
dc.subject.otheradjuvant treatment
dc.subject.otherneoadjuvant chemotherapy
dc.subject.othersentinel lymph node
dc.subject.othersystemic treatment
dc.subject.otherlocally advanced breast cancer
dc.subject.othermini-invasive treatment
dc.subject.otherliver metastases
dc.subject.otherhepatic surgery
dc.subject.otherpersonalized medicine
dc.subject.othersarcopenia
dc.subject.otherphysical performance
dc.subject.otherfrailty
dc.subject.otherolder cancer patients
dc.subject.otherclinical trial
dc.subject.otherpatient enrollment
dc.subject.otherartificial intelligence
dc.subject.othermachine learning
dc.subject.otherlung cancer
dc.subject.otheroncology
dc.subject.otherweb app
dc.subject.otherconventional CT and CT angiography
dc.subject.otherDIEP flap planning
dc.subject.othermultidisciplinary treatment
dc.subject.otherevidence-based medicine
dc.subject.otherpersonalized treatment
dc.subject.otheroncological outcomes
dc.subject.otherpatient quality of life
dc.subject.othernormal breast
dc.subject.otherbreast pathology
dc.subject.otherhormone receptor
dc.subject.otherhormone expression
dc.subject.otherlymphedema
dc.subject.otherlymphaticovenous anastomosis
dc.subject.othervascularized lymph node transfer
dc.subject.otherlymphatic microsurgery
dc.subject.otherradiotherapy
dc.subject.otheroligometastatic breast cancer
dc.subject.otherlocoregional therapy
dc.subject.otherCDK4/6 inhibitors
dc.subject.othermultidisciplinary
dc.subject.otherAMH
dc.subject.otherovarian reserve
dc.subject.otherpregnancy desire
dc.subject.othersubtypes breast cancer
dc.subject.othermiRNAs
dc.subject.otherbreast cancer treatment
dc.subject.othernext-generation-sequencing
dc.subject.othertarget therapy
dc.subject.otherold age
dc.subject.othersurvival
dc.subject.othervitamin D
dc.subject.otherductal breast cancer
dc.subject.otherin situ breast cancer
dc.subject.otherlobular breast cancer
dc.subject.otherhistology
dc.subject.othern/a
dc.titleInnovations in the Integrated Management of Breast Cancer
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-3801-3
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036538020
oapen.relation.isbn9783036538013
oapen.pages278
oapen.place.publicationBasel


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/